Economic impact of a rotavirus vaccine in Brazil
Constenla, Dagna O
Linhares, Alexandre da Costa
Rheingans, Richard D
Antil, Lynn R
Waldman, Eliseu A
Silva, Luiz J. da
The study was done to evaluate the cost-effectiveness of a national rotavirus vaccination programme in Brazilian children from the healthcare system perspective. A hypothetical annual birth-cohort was followed for a five-year period. Published and national administrative data were incorporated into a model to quantify the consequences of vaccination versus no vaccination. Main outcome measures included the reduction in disease burden, lives saved, and disability-adjusted life-years (DALYs) averted. A rotavirus vaccination programme in Brazil would prevent an estimated 1,804 deaths associated with gastroenteritis due to rotavirus, 91,127 hospitalizations, and 550,198 outpatient visits. Vaccination is likely to reduce 76 per cent of the overall healthcare burden of rotavirus-associated gastroenteritis in Brazil. At a vaccine price of US$ 7-8 per dose, the cost-effectiveness ratio would be US$ 643 per DALY averted. Rotavirus vaccination can reduce the burden of gastroenteritis due to rotavirus at a reasonable cost-effectiveness ratio.
xmlui.dri2xhtml.METS-1.0.item-citationCONSTENLA, Dagna O. et al. Economic impact of a rotavirus vaccine in Brazil. Journal of Health, Population and Nutrition, v. 26, n. 4, p. 388-396, Dec. 2008.
xmlui.dri2xhtml.METS-1.0.item-decsPrimaryVacinas contra Rotavirus
Infecções por Rotavirus
Estudos de Avaliação